Literature DB >> 14645369

DNA damage-binding proteins and heterogeneous nuclear ribonucleoprotein A1 function as constitutive KCS element components of the interferon-inducible RNA-dependent protein kinase promoter.

Sonali Das1, Simone Visosky Ward, Danielle Markle, Charles E Samuel.   

Abstract

Protein kinase regulated by RNA (PKR) plays important roles in many cellular processes including virus multiplication and cell growth, differentiation, and apoptosis. The promoter of the PKR gene possesses a novel 15-bp element designated KCS, positioned upstream of a consensus interferon (IFN)-stimulated response element, that is required for both basal and interferon-inducible transcription. Protein binding to the KCS element is not dependent upon IFN treatment and correlates with transcriptional activity of the PKR promoter. The identity of KCS-binding proteins (KBP) that selectively bind at the KCS element is largely unknown, except for the transcription factor Sp1. We now have purified KBP from HeLa cell nuclear extracts by ion-exchange and DNA-affinity chromatography steps and then identified four constituent proteins of the KBP complex by mass spectrometry and immunochemistry: KBP120 and KBP45 are the damaged DNA-binding protein subunits, p127 DDB1 and p48 DDB2, respectively; KBP100 is the transcription factor Sp1; and KBP35 is the heterogeneous nuclear ribonucleoprotein A1. The steady-state levels of these four KCS-binding proteins in human cells are not altered by IFN treatment. Components of the KBP complex bind selectively and constitutively to the KCS element in the absence of IFN treatment, both in vitro as measured by competition electrophoretic mobility shift assay (EMSA) and DNA pull-down assays and in vivo as measured by chromatin immunoprecipitation assays. Depletion of DDB2 by antisense strategy reduces KBP complex formation by EMSA. These results provide new insight into the biochemical identity and activity of proteins involved in PKR promoter function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645369     DOI: 10.1074/jbc.M312585200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death.

Authors:  Olivier Leupin; Séverine Bontron; Céline Schaeffer; Michel Strubin
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.

Authors:  Raffi Vartanian; Janine Masri; Jheralyn Martin; Cheri Cloninger; Brent Holmes; Nicholas Artinian; Alex Funk; Teresa Ruegg; Joseph Gera
Journal:  Mol Cancer Res       Date:  2010-12-06       Impact factor: 5.852

3.  Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches.

Authors:  Daniel Mayer; Kaaweh Molawi; Luis Martínez-Sobrido; Alexander Ghanem; Stefan Thomas; Sacha Baginsky; Jonas Grossmann; Adolfo García-Sastre; Martin Schwemmle
Journal:  J Proteome Res       Date:  2007-02       Impact factor: 4.466

Review 4.  A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative Disease.

Authors:  Joseph P Clarke; Patricia A Thibault; Hannah E Salapa; Michael C Levin
Journal:  Front Mol Biosci       Date:  2021-04-12

5.  hnRNPA1/UP1 Unfolds KRAS G-Quadruplexes and Feeds a Regulatory Axis Controlling Gene Expression.

Authors:  Annalisa Ferino; Julien Marquevielle; Himanshi Choudhary; Giorgio Cinque; Coralie Robert; Anne Bourdoncle; Raffaella Picco; Jean-Louis Mergny; Gilmar F Salgado; Luigi E Xodo
Journal:  ACS Omega       Date:  2021-11-30

Review 6.  hnRNP A1: the Swiss army knife of gene expression.

Authors:  Jacques Jean-Philippe; Sean Paz; Massimo Caputi
Journal:  Int J Mol Sci       Date:  2013-09-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.